Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000062391-97-000001
Filing Date
1997-01-09
Accepted
1997-01-09 00:00:00
Documents
4
Group Members
HMR PHARMA, INC.HOECHST MARION ROUSSEL INC
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 HMRI/HMR PHARMA AMEND 5 TO ONCOGENE 13D SC 13D/A 15955
2 EXHIBIT 99C TO ONCOGENE 13D EX-99 1013
3 EXHIBIT 99D TO ONCOGENE 13D EX-99 3715
4 EXHIBIT 99E TO ONCOGENE 13D EX-99 5072
  Complete submission text file 0000062391-97-000001.txt   28422
Mailing Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627
Business Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627 8169665000
HOECHST MARION ROUSSEL INC (Filed by) CIK: 0000062391 (see all company filings)

EIN.: 440565557 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-37954 | Film No.: 97503058
SIC: 2835 In Vitro & In Vivo Diagnostic Substances